Breaking News
Investing Pro 0
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started

Edwards Lifesciences cut to underperform at Bernstein as organic growth slows

Stock Markets Jan 31, 2023 12:16
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
EW
-0.53%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MDT
-0.16%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Sam Boughedda

Bernstein analysts double downgraded Edwards Lifesciences (NYSE:EW) to Underperform from Outperform on Tuesday, cutting the firm's price target on the stock to $66 from $95 per share.

The analysts said in a research note to clients that Edwards Lifesciences is a high-quality company and a leading medtech innovator, with investors having come to expect mid-teens revenue growth. However, they conceded that organic growth has slowed to 5.5% over the past two quarters, and the stock still trades at 30x-31x.

"We believe U.S. TAVR market growth could remain sluggish for a while, and worse, we believe Medtronic (NYSE:MDT) will take share from Edwards," wrote the analysts.

"Hospital staffing constraints are slowly improving, but EW's particular problems may take longer to fix, and COVID-related excess mortality may have depleted the TAM for TAVR by as much as 15%," the analysts added.

Altogether, Bernstein forecasts less than 7% organic growth for EW in 2023, declaring that "there are no big TAVR or TMTT catalysts that can save the stock in the near term."

In addition, the analysts feel that the company's guidance for 2023 seems optimistic, and the CEO transition adds a bit of uncertainty.

On Monday, Piper Sandler downgraded EW to Neutral, telling investors that the decision to cut the stock was based on factors including the U.S. TAVR market becoming increasingly competitive and the firm seeing a less-than-ideal stock set-up behind a lofty FY2023 guidance.

Edwards Lifesciences cut to underperform at Bernstein as organic growth slows
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email